{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:37:26Z","timestamp":1780922246311,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Gallbladder Large Cell Neuroendocrine Carcinoma (GB-LCNEC), an extremely rare pathological subtype of gallbladder malignancies, is characterized by high aggressiveness and insidious onset, often leading to poor prognosis and presenting significant clinical management challenges. This report presents the complete treatment course of a patient diagnosed with GB-LCNEC complicated by active Multiple Myeloma (MM), accompanied by a systematic review of relevant literature published over the past decade. Preoperative imaging revealed a gallbladder mass, which was pathologically confirmed postoperatively as GB-LCNEC through histological and immunohistochemical analysis. The tumor demonstrated large cell morphology, high mitotic activity (Ki-67 index of 50%), and strong expression of neuroendocrine markers, including Insulinoma-Associated Protein 1 (INSM1). Despite the concurrent diagnosis of active MM, a Multidisciplinary Team (MDT) successfully performed radical resection for gallbladder carcinoma, which included cholecystectomy, wedge resection of adjacent hepatic tissue, and regional lymphadenectomy at the hepatic hilum. An R0 resection was achieved, laying a solid foundation for postoperative management. Given the patient\u2019s limited tolerance to the standard Etoposide\u2013Cisplatin (EP) chemotherapy regimen, a milder, individualized approach using the Capecitabine\u2013Temozolomide (CAPTEM) regimen was selected. Simultaneously, the patient\u2019s MM was treated with the Daratumumab\u2013Lenalidomide\u2013Dexamethasone (DRD) regimen. At six-month follow-up, there was no evidence of recurrence or metastasis, and the patient maintained a favorable general condition. This case underscores that in highly aggressive malignancies such as GB-LCNEC, surgical resection remains a cornerstone of effective disease control and survival extension, even in the presence of severe comorbidities. MDT-based decision-making and personalized treatment strategies are essential for optimizing therapeutic outcomes and minimizing treatment-related risks. Future research should prioritize the development of multicenter clinical registries and large-scale molecular profiling, while also evaluating emerging modalities such as targeted therapies and immunotherapy to ultimately improve the prognosis of this rare tumor entity.<\/jats:p>","DOI":"10.3389\/fonc.2025.1664914","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:48:49Z","timestamp":1763718529000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Gallbladder large cell neuroendocrine carcinoma in a patient with multiple myeloma: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuhan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengding","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17998\/jlc.2025.02.27","article-title":"Epidemiology and genomic features of biliary tract cancer and its unique features in Korea","volume":"25","author":"Woo","year":"2025","journal-title":"J Liver Cancer."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2555518","article-title":"Epidemiological trends of early-onset gastrointestinal cancers from 1990 to 2021 and predictions for 2036: analysis from the global burden of disease study 2021","volume":"57","author":"Gong","year":"2025","journal-title":"Ann Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00423-021-02256-z","article-title":"Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome","volume":"407","author":"Gogna","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13000-022-01231-6","article-title":"Mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder: case report and literature review","volume":"17","author":"Ren","year":"2022","journal-title":"Diagn Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-020-00461-z","article-title":"Pure large cell neuroendocrine carcinoma of the gallbladder, is surgical relentlessness beneficial? A case report and literature review","volume":"10","author":"Tidjane","year":"2021","journal-title":"Int Cancer Conf J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1959_21","article-title":"Clinical features and outcomes analysis of Gallbladder neuroendocrine carcinoma","volume":"19","author":"Jiang","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5592525","article-title":"Neuroendocrine neoplasms of the gallbladder: A clinicopathological analysis of 13 patients and a review of the literature","volume":"2021","author":"Wang","year":"2021","journal-title":"Gastroenterol Res Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001536","article-title":"Neuroendocrine carcinomas of the gallbladder: A clinicopathologic and immunohistochemical analysis of 34 resected cases","volume":"44","author":"Lee","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-020-00412-3","article-title":"Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1954","article-title":"Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention","volume":"28","author":"Giraldo","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04794-7","article-title":"Risk of developing a second primary cancer following a renal cell carcinoma: a systematic review and meta-analysis","author":"Tundealao","year":"2025","journal-title":"Int Urol Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13073-025-01504-x","article-title":"MorphoITH: a framework for deconvolving intra-tumor heterogeneity using tissue morphology","volume":"17","author":"Nielsen","year":"2025","journal-title":"Genome Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12022-020-09605-6","article-title":"Gallbladder mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) arising in intracholecystic papillary neoplasm: clinicopathologic and molecular analysis of a case and review of the literature","volume":"31","author":"Sciarra","year":"2020","journal-title":"Endocr Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41421-022-00445-8","article-title":"Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Discov"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02843-0","article-title":"Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination","volume":"23","author":"Gromowski","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.09.008","article-title":"Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes","volume":"15","author":"Tarlow","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.05.036","article-title":"Primary mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: A case report and literature review","volume":"45","author":"Yu","year":"2022","journal-title":"Asian J Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.8444","article-title":"Large cell neuroendocrine carcinoma of gallbladder: A case report","volume":"62","author":"Sah","year":"2024","journal-title":"JNMA J Nepal Med Assoc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2015.12.045","article-title":"Survival: a rare outcome in large cell neuroendocrine carcinoma of the gallbladder","volume":"82","author":"Shapera","year":"2019","journal-title":"Acta Gastroenterol Belg."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2015.12.045","article-title":"Pure\u201d large cell neuroendocrine carcinoma of the gallbladder","author":"Buscemi","year":"2016","journal-title":"Rep Case Rev literature. Int J Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000534520","article-title":"Large cell neuroendocrine carcinoma of the gallbladder: where survival is a rare entity - case report and review of the literature","volume":"17","author":"Dhruv","year":"2023","journal-title":"Case Rep Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6956046","article-title":"A rare case of pure primary large cell neuroendocrine carcinoma of the gallbladder","volume":"2022","author":"Shackelford","year":"2022","journal-title":"Case Rep Oncol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108476","article-title":"A rare occurrence of a poorly differentiated large cell neuroendocrine carcinoma of the gallbladder: A case report and review of the literature","volume":"109","author":"Shaikh","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37398","article-title":"An unusual case of large cell neuroendocrine cancer of the gallbladder with mixed adenocarcinoma component in a patient with pancreatobiliary maljunction","volume":"15","author":"Fick","year":"2023","journal-title":"Cureus."},{"key":"B25","doi-asserted-by":"publisher","first-page":"bcr2018225141","DOI":"10.1136\/bcr-2018-225141","article-title":"Large cell neuroendocrine carcinoma and adenocarcinoma of gallbladder with concomitant hepatitis C infection","volume":"2018","author":"Soin","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12957-019-1666-9","article-title":"Repeat liver resection for pure large cell neuroendocrine carcinoma of the gallbladder: a favorable outcome","volume":"17","author":"Abutaka","year":"2019","journal-title":"World J Surg Oncol"},{"key":"B27","author":"Ma","year":"2021"},{"key":"B28","author":"Xu","year":"2019"},{"key":"B29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13023-019-1230-2","article-title":"Biliary tract large cell neuroendocrine carcinoma: current evidence","volume":"14","author":"Raiker","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00505-9","article-title":"Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors","volume":"43","author":"Mahalakshmi","year":"2020","journal-title":"Cell Oncol (Dordr)."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152445","article-title":"Prognostic factors and survival outcomes in resected biliary tract cancers: A multicenter retrospective analysis","volume":"17","author":"Ghidini","year":"2025","journal-title":"Cancers (Basel)."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32060328","article-title":"Prognostic factors and treatment outcomes in gallbladder cancer patients undergoing curative surgery: A multicenter retrospective cohort study","volume":"32","author":"Xu","year":"2025","journal-title":"Curr Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e85218","DOI":"10.7759\/cureus.85218","article-title":"Adenosquamous carcinoma of the gallbladder: A case report of a locally advanced carcinoma with a positive outcome","volume":"17","author":"Michel","year":"2025","journal-title":"Cureus."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003443","article-title":"Optimal surgical strategies in patients with T1 and T2 gallbladder cancer: necessity of lymph node dissection and liver resection: a retrospective cohort study","author":"Kim","year":"","journal-title":"Int J Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110284","article-title":"Textbook outcomes and minimally invasive techniques in resectab le gallbladder cancer: A global cohort study","author":"Cremona","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152436","article-title":"The impact of DDR gene mutations on the efficacy of etoposide plus cisplatin in grade 3 metastatic gastroenteropancreatic (GEP)-neuroendocrine carcinoma (NEC)","volume":"17","author":"Shin","year":"2025","journal-title":"Cancers (Basel)."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1346290","article-title":"Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1606850","article-title":"Case Report: Diagnosing and treating gallbladder neuroendocrine neoplasms through comparative analysis: a case series and literature review","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1664914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:48:49Z","timestamp":1763718529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1664914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":38,"alternative-id":["10.3389\/fonc.2025.1664914"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1664914","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1664914"}}